Concord Healthcare Group Co., Ltd. announced that its controlling shareholder Beijing Concord Medical Technology Co., Ltd. has pledged 35.60 million H shares—equivalent to 100% of Beijing Concord’s direct stake and 4.54% of the company’s total issued share capital—to China Credit Trust Co., Ltd. on 8 September 2026.
The share pledge secures a loan facility of up to RMB0.30 billion provided by China Credit Trust to the Concord Healthcare Group. On the same date, the previous pledge of identical share volume, which had backed a RMB0.50 billion facility disclosed on 4 November 2025, was fully released.
Concord Healthcare stated that China Credit Trust is an independent third party under Hong Kong Listing Rule 13.17.
Board composition remains unchanged, with Dr. Yang Jianyu serving as Chairman and Executive Director. The announcement was issued in Beijing on 8 September 2026.